These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 15336454

  • 1. Induction therapy in chronic hepatitis C: déjà-vu with pegylated interferons?
    Zeuzem S.
    J Hepatol; 2004 Sep; 41(3):488-90. PubMed ID: 15336454
    [No Abstract] [Full Text] [Related]

  • 2. Re-treating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: really safe and effective?
    Lo GH.
    Hepatology; 2009 Sep; 50(3):988; author reply 988-9. PubMed ID: 19714721
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation?
    Puoti M, Babudieri S, Rezza G, Viale P, Antonini MG, Maida I, Rossi S, Zanini B, Putzolu V, Fenu L, Baiguera C, Sassu S, Carosi G, Mura MS.
    Antivir Ther; 2004 Aug; 9(4):627-30. PubMed ID: 15456094
    [Abstract] [Full Text] [Related]

  • 7. Peginterferon and ribavirin for chronic hepatitis C.
    Hoofnagle JH, Seeff LB.
    N Engl J Med; 2006 Dec 07; 355(23):2444-51. PubMed ID: 17151366
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].
    Pár A, Tornai I, Szalay F.
    Orv Hetil; 2007 May 06; 148(18):819-26. PubMed ID: 17468063
    [Abstract] [Full Text] [Related]

  • 10. [Pegylated interferon: new progress in treatment for chronic hepatitis C].
    Boyer N, Marcellin P.
    Gastroenterol Clin Biol; 2000 May 06; 24(8-9):767-9. PubMed ID: 11011255
    [No Abstract] [Full Text] [Related]

  • 11. [PEG-interferons: significance for the treatment of viral hepatitis B and C].
    Wedemeyer H, Cornberg M, Manns MP.
    Dtsch Med Wochenschr; 2001 Jun 01; 126 Suppl 1():S68-75. PubMed ID: 11450618
    [No Abstract] [Full Text] [Related]

  • 12. Combination therapy with telaprevir and pegylated interferon suppresses both wild-type and resistant hepatitis C virus.
    Lang L.
    Gastroenterology; 2007 Jan 01; 132(1):5-6. PubMed ID: 17241851
    [No Abstract] [Full Text] [Related]

  • 13. [Interferon in the treatment of viral hepatitis. The interferon was discovered 50 years ago].
    Fehér J, Lengyel G.
    Orv Hetil; 2007 Aug 19; 148(33):1539-43. PubMed ID: 17686671
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C.
    Di Bisceglie AM, Ghalib RH, Hamzeh FM, Rustgi VK.
    J Viral Hepat; 2007 Oct 19; 14(10):721-9. PubMed ID: 17875007
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of pegylated interferon alpha 2a or 2b plus ribavirin in chronic hepatitis C patients.
    Yenice N, Mehtap O, Gümrah M, Arican N.
    Turk J Gastroenterol; 2006 Jun 19; 17(2):94-8. PubMed ID: 16830289
    [Abstract] [Full Text] [Related]

  • 17. [Peg-interferon or pegylated interferon].
    Taeron C.
    Rev Infirm; 2003 Jan 19; (87):51-3. PubMed ID: 12677910
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.